List of Excipients in API gabapentin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing gabapentin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | FD&C BLUE NO. 2 | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | GELATIN | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | LACTOSE | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | STARCH, CORN | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | TALC | |
| Parke-Davis Div of Pfizer Inc | NEURONTIN | gabapentin | 0071-0803 | TITANIUM DIOXIDE | |
| Assertio Therapeutics Inc | GRALISE | gabapentin | 13913-004 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing gabapentin
Detailed excipient profiles for gabapentin
Excipient focus: 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)
gabapentin drug variants containing 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)
| Company | Ingredient | NDC |
|---|---|---|
| Cardinal Health 107 LLC | gabapentin | 55154-8194 |
| American Health Packaging | gabapentin | 60687-580 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)
Excipient focus: ACESULFAME POTASSIUM
gabapentin drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Amneal Pharmaceuticals LLC | gabapentin | 65162-698 |
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ACETIC ACID
gabapentin drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | gabapentin | 17856-0311 |
| Atlantic Biologicals Corps | gabapentin | 17856-1311 |
| BioComp Pharma Inc | gabapentin | 44523-120 |
| Akorn | gabapentin | 50383-311 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing ACETIC ACID
Excipient focus: ALCOHOL
gabapentin drug variants containing ALCOHOL
gabapentin drug variants not containing ALCOHOL
Excipient focus: ALUMINUM HYDROXIDE
gabapentin drug variants containing ALUMINUM HYDROXIDE
gabapentin drug variants not containing ALUMINUM HYDROXIDE
Excipient focus: AMMONIA
gabapentin drug variants containing AMMONIA
gabapentin drug variants not containing AMMONIA
Excipient focus: ANHYDROUS LACTOSE
gabapentin drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | gabapentin | 0904-6665 |
| NorthStar RxLLC | gabapentin | 16714-503 |
| QPharma Inc | gabapentin | 42708-056 |
| QPharma Inc | gabapentin | 42708-120 |
| PD-Rx Pharmaceuticals Inc | gabapentin | 43063-673 |
| medsource pharmaceuticals | gabapentin | 45865-549 |
| A-S Medication Solutions | gabapentin | 50090-0896 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing ANHYDROUS LACTOSE
Excipient focus: ANISE
gabapentin drug variants containing ANISE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing ANISE
Excipient focus: BROWN IRON OXIDE
gabapentin drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | gabapentin | 69336-106 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing BROWN IRON OXIDE
Excipient focus: BUTYL ALCOHOL
gabapentin drug variants containing BUTYL ALCOHOL
gabapentin drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM CARBONATE
gabapentin drug variants containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutica North America Inc | gabapentin | 45861-111 |
| Direct Rx | gabapentin | 61919-102 |
| Direct Rx | gabapentin | 61919-492 |
| Sun Pharmaceutical Industries Inc | gabapentin | 62756-137 |
| TYA Pharmaceuticals | gabapentin | 64725-0138 |
| REMEDYREPACK INC | gabapentin | 70518-3759 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing CALCIUM CARBONATE
Excipient focus: CALCIUM STEARATE
gabapentin drug variants containing CALCIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 0228-2636 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6548 |
| NCS HealthCare of KY Inc dba Vangard Labs | gabapentin | 0615-6554 |
| Major Pharmaceuticals | gabapentin | 0904-6586 |
| Cardinal Health | gabapentin | 55154-7989 |
| Proficient Rx | gabapentin | 63187-006 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing CALCIUM STEARATE
Excipient focus: CALCIUM SULFATE DIHYDRATE
gabapentin drug variants containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutica North America Inc | gabapentin | 45861-111 |
| Direct Rx | gabapentin | 61919-102 |
| Direct Rx | gabapentin | 61919-492 |
| Sun Pharmaceutical Industries Inc | gabapentin | 62756-137 |
| TYA Pharmaceuticals | gabapentin | 64725-0138 |
| REMEDYREPACK INC | gabapentin | 70518-3759 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing CALCIUM SULFATE DIHYDRATE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
gabapentin drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| Amneal Pharmaceuticals LLC | gabapentin | 65162-698 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
gabapentin drug variants containing CELLULOSE, MICROCRYSTALLINE
gabapentin drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE
gabapentin drug variants containing COPOVIDONE
gabapentin drug variants not containing COPOVIDONE
Excipient focus: COPOVIDONE K25-31
gabapentin drug variants containing COPOVIDONE K25-31
gabapentin drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
gabapentin drug variants containing CROSCARMELLOSE SODIUM
gabapentin drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
gabapentin drug variants containing CROSPOVIDONE
gabapentin drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 33
gabapentin drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | gabapentin | 68071-3527 |
| REMEDYREPACK INC | gabapentin | 70518-3140 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
gabapentin drug variants containing D&C YELLOW NO. 10
gabapentin drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
gabapentin drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | gabapentin | 45963-555 |
| Unit Dose Services | gabapentin | 50436-5550 |
| RPK Pharmaceuticals Inc | gabapentin | 53002-3423 |
| RPK Pharmaceuticals Inc | gabapentin | 53002-4423 |
| Bryant Ranch Prepack | gabapentin | 63629-6792 |
| REMEDYREPACK INC | gabapentin | 70518-0267 |
| REMEDYREPACK INC | gabapentin | 70518-0332 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DEHYDRATED ALCOHOL
gabapentin drug variants containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | gabapentin | 16571-867 |
| Method Pharmaceuticals LLC | gabapentin | 58657-720 |
| Graviti Pharmaceuticals Private Limited | gabapentin | 69844-055 |
| Direct_Rx | gabapentin | 72189-524 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing DEHYDRATED ALCOHOL
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
gabapentin drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc (formerly Arbor Pharmaceuticals) | gabapentin enacarbil | 53451-0103 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 1
gabapentin drug variants containing FD&C BLUE NO. 1
gabapentin drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
gabapentin drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
gabapentin drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
gabapentin drug variants containing FD&C BLUE NO. 2
gabapentin drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
gabapentin drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
gabapentin drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 3
gabapentin drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | gabapentin | 66116-444 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
gabapentin drug variants containing FD&C RED NO. 40
gabapentin drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
gabapentin drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | gabapentin | 16590-492 |
| MedVantx Inc | gabapentin | 66116-444 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
gabapentin drug variants containing FERRIC OXIDE RED
gabapentin drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
gabapentin drug variants containing FERRIC OXIDE YELLOW
gabapentin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
gabapentin drug variants containing FERROSOFERRIC OXIDE
gabapentin drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
gabapentin drug variants containing GELATIN
gabapentin drug variants not containing GELATIN
Excipient focus: GLYCERIN
gabapentin drug variants containing GLYCERIN
gabapentin drug variants not containing GLYCERIN
Excipient focus: GLYCERYL BEHENATE
gabapentin drug variants containing GLYCERYL BEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | gabapentin | 16590-104 |
| Rebel Distributors Corp | gabapentin | 21695-058 |
| Pharmaceutica North America Inc | gabapentin | 45861-111 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing GLYCERYL BEHENATE
Excipient focus: GLYCERYL DIBEHENATE
gabapentin drug variants containing GLYCERYL DIBEHENATE
gabapentin drug variants not containing GLYCERYL DIBEHENATE
Excipient focus: HYDROCHLORIC ACID
gabapentin drug variants containing HYDROCHLORIC ACID
gabapentin drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYPROPYL CELLULOSE
gabapentin drug variants containing HYDROXYPROPYL CELLULOSE
gabapentin drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
gabapentin drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
gabapentin drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
gabapentin drug variants containing HYPROMELLOSE
gabapentin drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
gabapentin drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
gabapentin drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | gabapentin | 0440-5562 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
gabapentin drug variants containing HYPROMELLOSES
gabapentin drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
gabapentin drug variants containing ISOPROPYL ALCOHOL
gabapentin drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
gabapentin drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Parke-Davis Div of Pfizer Inc | gabapentin | 0071-0803 |
| STAT RX USA LLC | gabapentin | 16590-870 |
| Greenstone LLC | gabapentin | 59762-4030 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
gabapentin drug variants containing LACTOSE MONOHYDRATE
gabapentin drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
gabapentin drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | gabapentin | 13913-004 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Almatica Pharma LLC | gabapentin | 52427-803 |
| MedVantx Inc | gabapentin | 66116-444 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing LECITHIN, SOYBEAN
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
gabapentin drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
gabapentin drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
gabapentin drug variants containing MAGNESIUM STEARATE
gabapentin drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
gabapentin drug variants containing MANNITOL
gabapentin drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
gabapentin drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing METHYLPARABEN
Excipient focus: POLOXAMER 407
gabapentin drug variants containing POLOXAMER 407
gabapentin drug variants not containing POLOXAMER 407
Excipient focus: POLYETHYLENE GLYCOL
gabapentin drug variants containing POLYETHYLENE GLYCOL
gabapentin drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
gabapentin drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | gabapentin | 13913-004 |
| Camber Pharmaceuticals Inc | gabapentin | 31722-091 |
| Almatica Pharma LLC | gabapentin | 52427-803 |
| Megalith Pharmaceuticals Inc | gabapentin | 71717-102 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
gabapentin drug variants containing POLYETHYLENE GLYCOL 400
gabapentin drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
gabapentin drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 7000000
gabapentin drug variants containing POLYETHYLENE GLYCOL 7000000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing POLYETHYLENE GLYCOL 7000000
Excipient focus: POLYETHYLENE GLYCOL 8000
gabapentin drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | gabapentin | 50436-7286 |
| Lupin Pharmaceuticals Inc | gabapentin | 68180-348 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
gabapentin drug variants containing POLYETHYLENE GLYCOLS
gabapentin drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
gabapentin drug variants containing POLYSORBATE 80
gabapentin drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
gabapentin drug variants containing POLYVINYL ALCOHOL
gabapentin drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POTASSIUM HYDROXIDE
gabapentin drug variants containing POTASSIUM HYDROXIDE
gabapentin drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POTASSIUM SORBATE
gabapentin drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | gabapentin | 17856-0698 |
| Amneal Pharmaceuticals LLC | gabapentin | 65162-698 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing POTASSIUM SORBATE
Excipient focus: POVIDONE
gabapentin drug variants containing POVIDONE
gabapentin drug variants not containing POVIDONE
Excipient focus: POVIDONE K90
gabapentin drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | gabapentin | 68382-608 |
| Zydus Lifesciences Limited | gabapentin | 70771-1861 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing POVIDONE K90
Excipient focus: PROPYLENE GLYCOL
gabapentin drug variants containing PROPYLENE GLYCOL
gabapentin drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
gabapentin drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
gabapentin drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | gabapentin | 72888-104 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing SACCHARIN SODIUM
Excipient focus: SHELLAC
gabapentin drug variants containing SHELLAC
gabapentin drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
gabapentin drug variants containing SILICON DIOXIDE
gabapentin drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ACETATE
gabapentin drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Atlantic Biologicals Corps | gabapentin | 17856-0311 |
| Atlantic Biologicals Corps | gabapentin | 17856-1311 |
| BioComp Pharma Inc | gabapentin | 44523-120 |
| Akorn | gabapentin | 50383-311 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM HYDROXIDE
gabapentin drug variants containing SODIUM HYDROXIDE
gabapentin drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
gabapentin drug variants containing SODIUM LAURYL SULFATE
gabapentin drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
gabapentin drug variants containing STARCH, CORN
gabapentin drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
gabapentin drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | gabapentin | 69336-106 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: STRAWBERRY
gabapentin drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | gabapentin | 31722-069 |
| >Company | >Ingredient | >NDC |
gabapentin drug variants not containing STRAWBERRY
Excipient focus: TALC
gabapentin drug variants containing TALC
gabapentin drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
gabapentin drug variants containing TITANIUM DIOXIDE
gabapentin drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
gabapentin drug variants containing WATER
gabapentin drug variants not containing WATER
Excipient focus: XYLITOL
gabapentin drug variants containing XYLITOL
gabapentin drug variants not containing XYLITOL
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
